The global Transdermal Microneedle System market was valued at US$ 405 million in 2025 and is anticipated to reach US$ 640 million by 2032, at a CAGR of 6.8% from 2026 to 2032.

Transdermal Microneedle System Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Transdermal Microneedle System competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Transdermal microneedle systems are skin-applied drug delivery technologies that use arrays of microscopic needles to cross the stratum corneum and deliver medicines into the shallow layers of skin, enabling systemic or local therapy with minimal pain. They can be classified as soluble systems, where the microneedles are made from water-soluble/biodegradable materials that dissolve or swell in the skin to release the drug (often carrying the dose within the needle matrix), and insoluble systems, where the microneedles remain intact and function as solid or hollow structures to either create microchannels for subsequent drug diffusion or directly infuse liquid formulations through the needles. Consumer/cosmetic transdermal microneedle systems typically cost between $0.75 and $1.60 per patch. Vaccine transdermal microneedle systems cost between $0.85 and $5.00 per dose/patch.

Transdermal microneedle systems sit at the intersection of transdermal device manufacturing and drug-product supply. Upstream inputs include microneedle substrate materials (e.g., medical polymers, sugars/hydrogels for dissolving tips, metals/ceramics for solid arrays), drug substance or vaccine antigen plus stabilizing excipients, precision tooling (micro-molds, etching/laser micromachining equipment), and cleanroom-grade converting materials (backing films, pressure-sensitive adhesives, release liners, desiccants, foil pouches). Manufacturing typically combines microstructure fabrication (molding/etching/printing), drug loading or tip casting/coating, controlled drying and moisture management, assembly/lamination, packaging, and extensive in-process and release testing (dose uniformity, mechanical strength/insertion performance, bioburden/sterility approach, stability). Downstream, transdermal microneedle systems move through clinical-supply and commercial supply chains that resemble combination products: they require device + drug regulatory quality systems, validated packaging and distribution (often with humidity control), and channels that range from mass retail (cosmetic “microdart” patches) to healthcare procurement for vaccines/therapeutics; end-use workflows may include self-administration with minimal training, or administration protocols with applicators and traceability in immunization programs.

The transdermal microneedle system market is developing along two tracks: consumer skincare patches are already commercial and help normalize the form factor, while pharma/vaccine MAPs are advancing through clinical development and manufacturing scale-up as companies pursue easier administration, better patient acceptance, and potential reductions in cold-chain and sharps waste depending on formulation. Near-term competition is centered on platform performance (reliable skin penetration and dose delivery), manufacturability (high-throughput, low-defect microfabrication and drug-loading yields), and regulatory readiness for combination products, which together create high barriers to entry and favor a small set of platform owners and CDMOs. Adoption tends to be indication-specific: transdermal microneedle systems are most compelling where adherence, ease of use, and decentralized delivery matter (vaccination campaigns, chronic self-injected biologics, pediatric use), but they must compete against improved autoinjectors, nasal/oral alternatives, and established transdermal systems. Over the next several years, the key market inflection will be successful late-stage trials and the first large-scale approvals that validate cost, stability, and real-world usability—unlocking broader partnering, capacity investment, and standardized manufacturing/quality expectations across the ecosystem.

This report delivers a comprehensive overview of the global Transdermal Microneedle System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Transdermal Microneedle System. The Transdermal Microneedle System market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Transdermal Microneedle System market comprehensively. Regional market sizes by Type, by Application, by Microneedle Material, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Transdermal Microneedle System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Transdermal Microneedle System Market Report

Report Metric	Details
Report Name	Transdermal Microneedle System Market
Accounted market size in 2025	US$ 405 million
Forecasted market size in 2032	US$ 640 million
CAGR	6.8%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Dissolving Non-dissolving
Segment by Microneedle Material	Hyaluronic Acid Taurine PGA, PLA, PP
Segment by Form of Use	Patches Direct Topical
by Application	Medical Cosmetics
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Kindeva, Raphas, CosMED Pharmaceutical, Vaxess Technologies, Micron Biomedical, LTS Lohmann Therapie-Systeme, ArrayPatch, CeraVx, Zhongke Microneedle (Beijing) Technology, Zhuhai Youwe Biotechnology, Youwei (Zhuhai) Biotechnology, WCC Biomedical, Hisamitsu Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Microneedle Material, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Transdermal Microneedle System manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Transdermal Microneedle System sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Transdermal Microneedle System Market growing?

Ans: The Transdermal Microneedle System Market witnessing a CAGR of 6.8% during the forecast period 2026-2032.

What is the Transdermal Microneedle System Market size in 2032?

Ans: The Transdermal Microneedle System Market size in 2032 will be US$ 640 million.

Who are the main players in the Transdermal Microneedle System Market report?

Ans: The main players in the Transdermal Microneedle System Market are Kindeva, Raphas, CosMED Pharmaceutical, Vaxess Technologies, Micron Biomedical, LTS Lohmann Therapie-Systeme, ArrayPatch, CeraVx, Zhongke Microneedle (Beijing) Technology, Zhuhai Youwe Biotechnology, Youwei (Zhuhai) Biotechnology, WCC Biomedical, Hisamitsu Pharmaceutical

What are the Application segmentation covered in the Transdermal Microneedle System Market report?

Ans: The Applications covered in the Transdermal Microneedle System Market report are Medical, Cosmetics

What are the Type segmentation covered in the Transdermal Microneedle System Market report?

Ans: The Types covered in the Transdermal Microneedle System Market report are Dissolving, Non-dissolving

1 Transdermal Microneedle System Market Overview

1.1 Product Definition

1.2 Transdermal Microneedle System by Type

1.2.1 Global Transdermal Microneedle System Market Value by Type: 2025 vs 2032

1.2.2 Dissolving

1.2.3 Non-dissolving

1.3 Transdermal Microneedle System by Microneedle Material

1.3.1 Global Transdermal Microneedle System Market Value by Microneedle Material: 2025 vs 2032

1.3.2 Hyaluronic Acid

1.3.3 Taurine

1.3.4 PGA, PLA, PP

1.4 Transdermal Microneedle System by Form of Use

1.4.1 Global Transdermal Microneedle System Market Value by Form of Use: 2025 vs 2032

1.4.2 Patches

1.4.3 Direct Topical

1.5 Transdermal Microneedle System by Application

1.5.1 Global Transdermal Microneedle System Market Value by Application: 2025 vs 2032

1.5.2 Medical

1.5.3 Cosmetics

1.6 Global Transdermal Microneedle System Market Size Estimates and Forecasts

1.6.1 Global Transdermal Microneedle System Revenue 2021–2032

1.6.2 Global Transdermal Microneedle System Sales 2021–2032

1.6.3 Global Transdermal Microneedle System Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Transdermal Microneedle System Market Competition by Manufacturers

2.1 Global Transdermal Microneedle System Sales Market Share by Manufacturers (2021–2026)

2.2 Global Transdermal Microneedle System Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Transdermal Microneedle System Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Transdermal Microneedle System, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Transdermal Microneedle System, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Transdermal Microneedle System, Product Types and Applications

2.7 Global Key Manufacturers of Transdermal Microneedle System, Date of Entry into the Industry

2.8 Global Transdermal Microneedle System Market Competitive Situation and Trends

2.8.1 Global Transdermal Microneedle System Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Transdermal Microneedle System Players Market Share by Revenue

2.8.3 Global Transdermal Microneedle System Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Transdermal Microneedle System Market Scenario by Region

3.1 Global Transdermal Microneedle System Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Transdermal Microneedle System Sales by Region: 2021–2032

3.2.1 Global Transdermal Microneedle System Sales by Region: 2021–2026

3.2.2 Global Transdermal Microneedle System Sales by Region: 2027–2032

3.3 Global Transdermal Microneedle System Revenue by Region: 2021–2032

3.3.1 Global Transdermal Microneedle System Revenue by Region: 2021–2026

3.3.2 Global Transdermal Microneedle System Revenue by Region: 2027–2032

3.4 North America Transdermal Microneedle System Market Facts & Figures by Country

3.4.1 North America Transdermal Microneedle System Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Transdermal Microneedle System Sales by Country (2021–2032)

3.4.3 North America Transdermal Microneedle System Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Transdermal Microneedle System Market Facts & Figures by Country

3.5.1 Europe Transdermal Microneedle System Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Transdermal Microneedle System Sales by Country (2021–2032)

3.5.3 Europe Transdermal Microneedle System Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Transdermal Microneedle System Market Facts & Figures by Region

3.6.1 Asia Pacific Transdermal Microneedle System Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Transdermal Microneedle System Sales by Region (2021–2032)

3.6.3 Asia Pacific Transdermal Microneedle System Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Transdermal Microneedle System Market Facts & Figures by Country

3.7.1 Latin America Transdermal Microneedle System Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Transdermal Microneedle System Sales by Country (2021–2032)

3.7.3 Latin America Transdermal Microneedle System Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Transdermal Microneedle System Market Facts & Figures by Country

3.8.1 Middle East and Africa Transdermal Microneedle System Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Transdermal Microneedle System Sales by Country (2021–2032)

3.8.3 Middle East and Africa Transdermal Microneedle System Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Transdermal Microneedle System Sales by Type (2021–2032)

4.1.1 Global Transdermal Microneedle System Sales by Type (2021–2026)

4.1.2 Global Transdermal Microneedle System Sales by Type (2027–2032)

4.1.3 Global Transdermal Microneedle System Sales Market Share by Type (2021–2032)

4.2 Global Transdermal Microneedle System Revenue by Type (2021–2032)

4.2.1 Global Transdermal Microneedle System Revenue by Type (2021–2026)

4.2.2 Global Transdermal Microneedle System Revenue by Type (2027–2032)

4.2.3 Global Transdermal Microneedle System Revenue Market Share by Type (2021–2032)

4.3 Global Transdermal Microneedle System Price by Type (2021–2032)

5 Segment by Application

5.1 Global Transdermal Microneedle System Sales by Application (2021–2032)

5.1.1 Global Transdermal Microneedle System Sales by Application (2021–2026)

5.1.2 Global Transdermal Microneedle System Sales by Application (2027–2032)

5.1.3 Global Transdermal Microneedle System Sales Market Share by Application (2021–2032)

5.2 Global Transdermal Microneedle System Revenue by Application (2021–2032)

5.2.1 Global Transdermal Microneedle System Revenue by Application (2021–2026)

5.2.2 Global Transdermal Microneedle System Revenue by Application (2027–2032)

5.2.3 Global Transdermal Microneedle System Revenue Market Share by Application (2021–2032)

5.3 Global Transdermal Microneedle System Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Kindeva

6.1.1 Kindeva Company Information

6.1.2 Kindeva Description and Business Overview

6.1.3 Kindeva Transdermal Microneedle System Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Kindeva Transdermal Microneedle System Product Portfolio

6.1.5 Kindeva Recent Developments/Updates

6.2 Raphas

6.2.1 Raphas Company Information

6.2.2 Raphas Description and Business Overview

6.2.3 Raphas Transdermal Microneedle System Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Raphas Transdermal Microneedle System Product Portfolio

6.2.5 Raphas Recent Developments/Updates

6.3 CosMED Pharmaceutical

6.3.1 CosMED Pharmaceutical Company Information

6.3.2 CosMED Pharmaceutical Description and Business Overview

6.3.3 CosMED Pharmaceutical Transdermal Microneedle System Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 CosMED Pharmaceutical Transdermal Microneedle System Product Portfolio

6.3.5 CosMED Pharmaceutical Recent Developments/Updates

6.4 Vaxess Technologies

6.4.1 Vaxess Technologies Company Information

6.4.2 Vaxess Technologies Description and Business Overview

6.4.3 Vaxess Technologies Transdermal Microneedle System Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Vaxess Technologies Transdermal Microneedle System Product Portfolio

6.4.5 Vaxess Technologies Recent Developments/Updates

6.5 Micron Biomedical

6.5.1 Micron Biomedical Company Information

6.5.2 Micron Biomedical Description and Business Overview

6.5.3 Micron Biomedical Transdermal Microneedle System Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Micron Biomedical Transdermal Microneedle System Product Portfolio

6.5.5 Micron Biomedical Recent Developments/Updates

6.6 LTS Lohmann Therapie-Systeme

6.6.1 LTS Lohmann Therapie-Systeme Company Information

6.6.2 LTS Lohmann Therapie-Systeme Description and Business Overview

6.6.3 LTS Lohmann Therapie-Systeme Transdermal Microneedle System Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 LTS Lohmann Therapie-Systeme Transdermal Microneedle System Product Portfolio

6.6.5 LTS Lohmann Therapie-Systeme Recent Developments/Updates

6.7 ArrayPatch

6.7.1 ArrayPatch Company Information

6.7.2 ArrayPatch Description and Business Overview

6.7.3 ArrayPatch Transdermal Microneedle System Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 ArrayPatch Transdermal Microneedle System Product Portfolio

6.7.5 ArrayPatch Recent Developments/Updates

6.8 CeraVx

6.8.1 CeraVx Company Information

6.8.2 CeraVx Description and Business Overview

6.8.3 CeraVx Transdermal Microneedle System Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 CeraVx Transdermal Microneedle System Product Portfolio

6.8.5 CeraVx Recent Developments/Updates

6.9 Zhongke Microneedle (Beijing) Technology

6.9.1 Zhongke Microneedle (Beijing) Technology Company Information

6.9.2 Zhongke Microneedle (Beijing) Technology Description and Business Overview

6.9.3 Zhongke Microneedle (Beijing) Technology Transdermal Microneedle System Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Zhongke Microneedle (Beijing) Technology Transdermal Microneedle System Product Portfolio

6.9.5 Zhongke Microneedle (Beijing) Technology Recent Developments/Updates

6.10 Zhuhai Youwe Biotechnology

6.10.1 Zhuhai Youwe Biotechnology Company Information

6.10.2 Zhuhai Youwe Biotechnology Description and Business Overview

6.10.3 Zhuhai Youwe Biotechnology Transdermal Microneedle System Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Zhuhai Youwe Biotechnology Transdermal Microneedle System Product Portfolio

6.10.5 Zhuhai Youwe Biotechnology Recent Developments/Updates

6.11 Youwei (Zhuhai) Biotechnology

6.11.1 Youwei (Zhuhai) Biotechnology Company Information

6.11.2 Youwei (Zhuhai) Biotechnology Description and Business Overview

6.11.3 Youwei (Zhuhai) Biotechnology Transdermal Microneedle System Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Youwei (Zhuhai) Biotechnology Transdermal Microneedle System Product Portfolio

6.11.5 Youwei (Zhuhai) Biotechnology Recent Developments/Updates

6.12 WCC Biomedical

6.12.1 WCC Biomedical Company Information

6.12.2 WCC Biomedical Description and Business Overview

6.12.3 WCC Biomedical Transdermal Microneedle System Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 WCC Biomedical Transdermal Microneedle System Product Portfolio

6.12.5 WCC Biomedical Recent Developments/Updates

6.13 Hisamitsu Pharmaceutical

6.13.1 Hisamitsu Pharmaceutical Company Information

6.13.2 Hisamitsu Pharmaceutical Description and Business Overview

6.13.3 Hisamitsu Pharmaceutical Transdermal Microneedle System Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Hisamitsu Pharmaceutical Transdermal Microneedle System Product Portfolio

6.13.5 Hisamitsu Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Transdermal Microneedle System Industry Chain Analysis

7.2 Transdermal Microneedle System Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Transdermal Microneedle System Production Mode & Process Analysis

7.4 Transdermal Microneedle System Sales and Marketing

7.4.1 Transdermal Microneedle System Sales Channels

7.4.2 Transdermal Microneedle System Distributors

7.5 Transdermal Microneedle System Customer Analysis

8 Transdermal Microneedle System Market Dynamics

8.1 Transdermal Microneedle System Industry Trends

8.2 Transdermal Microneedle System Market Drivers

8.3 Transdermal Microneedle System Market Challenges

8.4 Transdermal Microneedle System Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

KINDEVA

Raphas

Cosmed Pharmaceutical

Vaxess Technologies

Micron Biomedical

LTS Lohmann Therapie-Systeme

ArrayPatch

CeraVx

Zhongke Microneedle (Beijing) Technology

Zhuhai Youwe Biotechnology

Youwei (Zhuhai) Biotechnology

WCC Biomedical

Hisamitsu Pharmaceutical

List of Tables

Table 1. Global Transdermal Microneedle System Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Transdermal Microneedle System Market Value by Microneedle Material (US$ Million), 2025 vs 2032

Table 3. Global Transdermal Microneedle System Market Value by Form of Use (US$ Million), 2025 vs 2032

Table 4. Global Transdermal Microneedle System Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Transdermal Microneedle System Market Competitive Situation by Manufacturers in 2025

Table 6. Global Transdermal Microneedle System Sales (K Units) of Key Manufacturers (2021–2026)

Table 7. Global Transdermal Microneedle System Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Transdermal Microneedle System Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Transdermal Microneedle System Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Transdermal Microneedle System Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Transdermal Microneedle System, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Transdermal Microneedle System, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Transdermal Microneedle System, Product Types and Applications

Table 14. Global Key Manufacturers of Transdermal Microneedle System, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Transdermal Microneedle System Companies by Tier (Tier 1, Tier 2, Tier 3), based on Transdermal Microneedle System Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Transdermal Microneedle System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Transdermal Microneedle System Sales by Region (K Units), 2021–2026

Table 20. Global Transdermal Microneedle System Sales Market Share by Region (2021–2026)

Table 21. Global Transdermal Microneedle System Sales by Region (K Units), 2027–2032

Table 22. Global Transdermal Microneedle System Sales Market Share by Region (2027–2032)

Table 23. Global Transdermal Microneedle System Revenue by Region (US$ Million), 2021–2026

Table 24. Global Transdermal Microneedle System Revenue Market Share by Region (2021–2026)

Table 25. Global Transdermal Microneedle System Revenue by Region (US$ Million), 2027–2032

Table 26. Global Transdermal Microneedle System Revenue Market Share by Region (2027–2032)

Table 27. North America Transdermal Microneedle System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Transdermal Microneedle System Sales by Country (K Units), 2021–2026

Table 29. North America Transdermal Microneedle System Sales by Country (K Units), 2027–2032

Table 30. North America Transdermal Microneedle System Revenue by Country (US$ Million), 2021–2026

Table 31. North America Transdermal Microneedle System Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Transdermal Microneedle System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Transdermal Microneedle System Sales by Country (K Units), 2021–2026

Table 34. Europe Transdermal Microneedle System Sales by Country (K Units), 2027–2032

Table 35. Europe Transdermal Microneedle System Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Transdermal Microneedle System Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Transdermal Microneedle System Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Transdermal Microneedle System Sales by Region (K Units), 2021–2026

Table 39. Asia Pacific Transdermal Microneedle System Sales by Region (K Units), 2027–2032

Table 40. Asia Pacific Transdermal Microneedle System Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Transdermal Microneedle System Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Transdermal Microneedle System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Transdermal Microneedle System Sales by Country (K Units), 2021–2026

Table 44. Latin America Transdermal Microneedle System Sales by Country (K Units), 2027–2032

Table 45. Latin America Transdermal Microneedle System Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Transdermal Microneedle System Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Transdermal Microneedle System Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Transdermal Microneedle System Sales by Country (K Units), 2021–2026

Table 49. Middle East and Africa Transdermal Microneedle System Sales by Country (K Units), 2027–2032

Table 50. Middle East and Africa Transdermal Microneedle System Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Transdermal Microneedle System Revenue by Country (US$ Million), 2027–2032

Table 52. Global Transdermal Microneedle System Sales (K Units) by Type (2021–2026)

Table 53. Global Transdermal Microneedle System Sales (K Units) by Type (2027–2032)

Table 54. Global Transdermal Microneedle System Sales Market Share by Type (2021–2026)

Table 55. Global Transdermal Microneedle System Sales Market Share by Type (2027–2032)

Table 56. Global Transdermal Microneedle System Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Transdermal Microneedle System Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Transdermal Microneedle System Revenue Market Share by Type (2021–2026)

Table 59. Global Transdermal Microneedle System Revenue Market Share by Type (2027–2032)

Table 60. Global Transdermal Microneedle System Price (US$/Unit) by Type (2021–2026)

Table 61. Global Transdermal Microneedle System Price (US$/Unit) by Type (2027–2032)

Table 62. Global Transdermal Microneedle System Sales (K Units) by Application (2021–2026)

Table 63. Global Transdermal Microneedle System Sales (K Units) by Application (2027–2032)

Table 64. Global Transdermal Microneedle System Sales Market Share by Application (2021–2026)

Table 65. Global Transdermal Microneedle System Sales Market Share by Application (2027–2032)

Table 66. Global Transdermal Microneedle System Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Transdermal Microneedle System Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Transdermal Microneedle System Revenue Market Share by Application (2021–2026)

Table 69. Global Transdermal Microneedle System Revenue Market Share by Application (2027–2032)

Table 70. Global Transdermal Microneedle System Price (US$/Unit) by Application (2021–2026)

Table 71. Global Transdermal Microneedle System Price (US$/Unit) by Application (2027–2032)

Table 72. Kindeva Company Information

Table 73. Kindeva Description and Business Overview

Table 74. Kindeva Transdermal Microneedle System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 75. Kindeva Transdermal Microneedle System Product

Table 76. Kindeva Recent Developments/Updates

Table 77. Raphas Company Information

Table 78. Raphas Description and Business Overview

Table 79. Raphas Transdermal Microneedle System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 80. Raphas Transdermal Microneedle System Product

Table 81. Raphas Recent Developments/Updates

Table 82. CosMED Pharmaceutical Company Information

Table 83. CosMED Pharmaceutical Description and Business Overview

Table 84. CosMED Pharmaceutical Transdermal Microneedle System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 85. CosMED Pharmaceutical Transdermal Microneedle System Product

Table 86. CosMED Pharmaceutical Recent Developments/Updates

Table 87. Vaxess Technologies Company Information

Table 88. Vaxess Technologies Description and Business Overview

Table 89. Vaxess Technologies Transdermal Microneedle System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 90. Vaxess Technologies Transdermal Microneedle System Product

Table 91. Vaxess Technologies Recent Developments/Updates

Table 92. Micron Biomedical Company Information

Table 93. Micron Biomedical Description and Business Overview

Table 94. Micron Biomedical Transdermal Microneedle System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 95. Micron Biomedical Transdermal Microneedle System Product

Table 96. Micron Biomedical Recent Developments/Updates

Table 97. LTS Lohmann Therapie-Systeme Company Information

Table 98. LTS Lohmann Therapie-Systeme Description and Business Overview

Table 99. LTS Lohmann Therapie-Systeme Transdermal Microneedle System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 100. LTS Lohmann Therapie-Systeme Transdermal Microneedle System Product

Table 101. LTS Lohmann Therapie-Systeme Recent Developments/Updates

Table 102. ArrayPatch Company Information

Table 103. ArrayPatch Description and Business Overview

Table 104. ArrayPatch Transdermal Microneedle System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 105. ArrayPatch Transdermal Microneedle System Product

Table 106. ArrayPatch Recent Developments/Updates

Table 107. CeraVx Company Information

Table 108. CeraVx Description and Business Overview

Table 109. CeraVx Transdermal Microneedle System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 110. CeraVx Transdermal Microneedle System Product

Table 111. CeraVx Recent Developments/Updates

Table 112. Zhongke Microneedle (Beijing) Technology Company Information

Table 113. Zhongke Microneedle (Beijing) Technology Description and Business Overview

Table 114. Zhongke Microneedle (Beijing) Technology Transdermal Microneedle System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 115. Zhongke Microneedle (Beijing) Technology Transdermal Microneedle System Product

Table 116. Zhongke Microneedle (Beijing) Technology Recent Developments/Updates

Table 117. Zhuhai Youwe Biotechnology Company Information

Table 118. Zhuhai Youwe Biotechnology Description and Business Overview

Table 119. Zhuhai Youwe Biotechnology Transdermal Microneedle System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 120. Zhuhai Youwe Biotechnology Transdermal Microneedle System Product

Table 121. Zhuhai Youwe Biotechnology Recent Developments/Updates

Table 122. Youwei (Zhuhai) Biotechnology Company Information

Table 123. Youwei (Zhuhai) Biotechnology Description and Business Overview

Table 124. Youwei (Zhuhai) Biotechnology Transdermal Microneedle System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 125. Youwei (Zhuhai) Biotechnology Transdermal Microneedle System Product

Table 126. Youwei (Zhuhai) Biotechnology Recent Developments/Updates

Table 127. WCC Biomedical Company Information

Table 128. WCC Biomedical Description and Business Overview

Table 129. WCC Biomedical Transdermal Microneedle System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 130. WCC Biomedical Transdermal Microneedle System Product

Table 131. WCC Biomedical Recent Developments/Updates

Table 132. Hisamitsu Pharmaceutical Company Information

Table 133. Hisamitsu Pharmaceutical Description and Business Overview

Table 134. Hisamitsu Pharmaceutical Transdermal Microneedle System Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 135. Hisamitsu Pharmaceutical Transdermal Microneedle System Product

Table 136. Hisamitsu Pharmaceutical Recent Developments/Updates

Table 137. Key Raw Materials Lists

Table 138. Raw Materials Key Suppliers Lists

Table 139. Transdermal Microneedle System Distributors List

Table 140. Transdermal Microneedle System Customers List

Table 141. Transdermal Microneedle System Market Trends

Table 142. Transdermal Microneedle System Market Drivers

Table 143. Transdermal Microneedle System Market Challenges

Table 144. Transdermal Microneedle System Market Restraints

Table 145. Research Programs/Design for This Report

Table 146. Key Data Information from Secondary Sources

Table 147. Key Data Information from Primary Sources

Table 148. Authors List of This Report

List of Figures

Figure 1. Product Picture of Transdermal Microneedle System

Figure 2. Global Transdermal Microneedle System Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Transdermal Microneedle System Market Share by Type: 2025 & 2032

Figure 4. Dissolving Product Picture

Figure 5. Non-dissolving Product Picture

Figure 6. Global Transdermal Microneedle System Market Value by Microneedle Material (US$ Million), 2021–2032

Figure 7. Global Transdermal Microneedle System Market Share by Microneedle Material: 2025 vs 2032

Figure 8. Hyaluronic Acid Product Picture

Figure 9. Taurine Product Picture

Figure 10. PGA, PLA, PP Product Picture

Figure 11. Global Transdermal Microneedle System Market Value by Form of Use (US$ Million), 2021–2032

Figure 12. Global Transdermal Microneedle System Market Share by Form of Use: 2025 vs 2032

Figure 13. Patches Product Picture

Figure 14. Direct Topical Product Picture

Figure 15. Global Transdermal Microneedle System Market Value by Application (US$ Million), 2021–2032

Figure 16. Global Transdermal Microneedle System Market Share by Application: 2025 & 2032

Figure 17. Medical

Figure 18. Cosmetics

Figure 19. Global Transdermal Microneedle System Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 20. Global Transdermal Microneedle System Market Size (US$ Million), 2021–2032

Figure 21. Global Transdermal Microneedle System Sales (K Units), 2021–2032

Figure 22. Global Transdermal Microneedle System Average Price (US$/Unit), 2021–2032

Figure 23. Transdermal Microneedle System Report Years Considered

Figure 24. Transdermal Microneedle System Sales Share by Manufacturers in 2025

Figure 25. Global Transdermal Microneedle System Revenue Share by Manufacturers in 2025

Figure 26. Top 5 and Top 10 Global Transdermal Microneedle System Players: Market Share by Revenue in Transdermal Microneedle System in 2025

Figure 27. Transdermal Microneedle System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 28. Global Transdermal Microneedle System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 29. North America Transdermal Microneedle System Sales Market Share by Country (2021–2032)

Figure 30. North America Transdermal Microneedle System Revenue Market Share by Country (2021–2032)

Figure 31. United States Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Canada Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Europe Transdermal Microneedle System Sales Market Share by Country (2021–2032)

Figure 34. Europe Transdermal Microneedle System Revenue Market Share by Country (2021–2032)

Figure 35. Germany Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. France Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. U.K. Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Italy Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Russia Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Asia Pacific Transdermal Microneedle System Sales Market Share by Region (2021–2032)

Figure 41. Asia Pacific Transdermal Microneedle System Revenue Market Share by Region (2021–2032)

Figure 42. China Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Japan Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. South Korea Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. India Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Australia Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. China Taiwan Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Indonesia Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Thailand Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Malaysia Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Latin America Transdermal Microneedle System Sales Market Share by Country (2021–2032)

Figure 52. Latin America Transdermal Microneedle System Revenue Market Share by Country (2021–2032)

Figure 53. Mexico Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Brazil Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Argentina Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Middle East and Africa Transdermal Microneedle System Sales Market Share by Country (2021–2032)

Figure 57. Middle East and Africa Transdermal Microneedle System Revenue Market Share by Country (2021–2032)

Figure 58. Turkey Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 59. Saudi Arabia Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 60. UAE Transdermal Microneedle System Revenue Growth Rate (US$ Million), 2021–2032

Figure 61. Global Sales Market Share of Transdermal Microneedle System by Type (2021–2032)

Figure 62. Global Revenue Market Share of Transdermal Microneedle System by Type (2021–2032)

Figure 63. Global Transdermal Microneedle System Price (US$/Unit) by Type (2021–2032)

Figure 64. Global Sales Market Share of Transdermal Microneedle System by Application (2021–2032)

Figure 65. Global Revenue Market Share of Transdermal Microneedle System by Application (2021–2032)

Figure 66. Global Transdermal Microneedle System Price (US$/Unit) by Application (2021–2032)

Figure 67. Transdermal Microneedle System Value Chain

Figure 68. Channels of Distribution (Direct Vs Distribution)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions